{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T23:28:29Z","timestamp":1772926109239,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.amjcard.2025.08.063","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T23:16:27Z","timestamp":1756854987000},"page":"158-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Angiotensin Receptor-Neprilysin Inhibitors and Mortality Among Patients With HFrEF"],"prefix":"10.1016","volume":"258","author":[{"given":"Henrik","family":"Svanstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Frederick","family":"Mkoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Hviid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amjcard.2025.08.063_bib0001","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart Failure With Reduced Ejection Fraction: A Review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2025.08.063_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077025","article-title":"Advances in management of heart failure","author":"Heidenreich","year":"2024","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.amjcard.2025.08.063_bib0003","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1016\/j.amjcard.2025.08.063_bib0004","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.amjcard.2025.08.063_bib0005","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.amjcard.2025.08.063_bib0006","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ejhf.788","article-title":"What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?","volume":"19","author":"Pellicori","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.amjcard.2025.08.063_bib0007","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jchf.2017.03.007","article-title":"Patients Not Meeting PARADIGM-HF Enrollment Criteria Are Eligible for Sacubitril\/Valsartan on the Basis of FDA Approval: The Need to Close the Gap","volume":"5","author":"Perez","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2025.08.063_bib0008","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/VHRM.S114784","article-title":"Profile of sacubitril\/valsartan in the treatment of heart failure: patient selection and perspectives","volume":"13","author":"Yandrapalli","year":"2017","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"10.1016\/j.amjcard.2025.08.063_bib0009","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jchf.2019.08.003","article-title":"Comparative Effectiveness of Sacubitril-Valsartan Versus ACE\/ARB Therapy in Heart Failure With Reduced Ejection Fraction","volume":"8","author":"Tan","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.amjcard.2025.08.063_bib0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00392-022-02124-w","article-title":"Real-world comparative effectiveness of ARNI versus ACEi\/ARB in HF with reduced or mildly reduced ejection fraction","volume":"112","author":"Fu","year":"2023","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"10.1016\/j.amjcard.2025.08.063_bib0011","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1002\/ehf2.12924","article-title":"Sacubitril\/valsartan vs. angiotensin receptor inhibition in heart failure: a real-world study in Taiwan","volume":"7","author":"Chang","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"17","key":"10.1016\/j.amjcard.2025.08.063_bib0012","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/heartjnl-2021-319405","article-title":"Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care","volume":"107","author":"Desai","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2025.08.063_bib0013","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/CLEP.S99504","article-title":"The Danish Heart Failure Registry","volume":"8","author":"Schj\u00f8dt","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.amjcard.2025.08.063_bib0014","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2217\/cer.12.12","article-title":"Newly marketed medications present unique challenges for nonrandomized comparative effectiveness analyses","volume":"1","author":"Rassen","year":"2012","journal-title":"J Comp Eff Res"},{"issue":"6","key":"10.1016\/j.amjcard.2025.08.063_bib0015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.1494","article-title":"Heart Failure Association of the European Society of Cardiology. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations","volume":"21","author":"Mueller","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.amjcard.2025.08.063_bib0016","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/pds.4107","article-title":"Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores","volume":"26","author":"Suissa","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7 Suppl","key":"10.1016\/j.amjcard.2025.08.063_bib0017","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"8","key":"10.1016\/j.amjcard.2025.08.063_bib0018","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"7 Suppl","key":"10.1016\/j.amjcard.2025.08.063_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish Register of Causes of Death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.amjcard.2025.08.063_bib0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.amjcard.2025.08.063_bib0021","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/CLEP.S245060","article-title":"Existing Data Sources in Clinical Epidemiology: Laboratory Information System Databases in Denmark","volume":"12","author":"Arendt","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"451","key":"10.1016\/j.amjcard.2025.08.063_bib0022","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/01621459.2000.10474263","article-title":"Estimating and Using Propensity Scores with Partially Missing Data","volume":"95","author":"D'Agostino","year":"2000","journal-title":"Journal of the American Statistical Association"},{"issue":"1","key":"10.1016\/j.amjcard.2025.08.063_bib0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/EDE.0000000000000409","article-title":"Selection Bias Due to Loss to Follow Up in Cohort Studies","volume":"27","author":"Howe","year":"2016","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.amjcard.2025.08.063_bib0024","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"issue":"5","key":"10.1016\/j.amjcard.2025.08.063_bib0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/EDE.0000000000001521","article-title":"Selection of Comparator Group in Observational Drug Safety Studies: Alternatives to the Active Comparator New User Design","volume":"33","author":"Wintzell","year":"2022","journal-title":"Epidemiology"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925005351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925005351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:58:22Z","timestamp":1772855902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914925005351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"alternative-id":["S0002914925005351"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.08.063","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin Receptor-Neprilysin Inhibitors and Mortality Among Patients With HFrEF","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.08.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}